Computed microtomography of bone specimens for rapid analysis of bone changes associated with malignancy

Anatomical Record

Volumn 293, Issue 7, 2010, Pages 1125-1133

  Chappard, Daniel ^a   Libouban, Hélène ^a   Legrand, Erick ^a,b   Ifrah, Norbert ^b   Masson, Charles ^a,b   Baslé, Michel Felix ^a   Audran, Maurice ^a,b  

^a Universite d'Angers   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

3D analysis; Bone metastasis; Computed microtomography; Myeloma; Osteolysis; Osteosclerosis

Indexed keywords

ARTICLE; BONE; BONE BIOPSY; BONE METASTASIS; BREAST CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOMA; MAJOR CLINICAL STUDY; MICRO-COMPUTED TOMOGRAPHY; MONOCLONAL IMMUNOGLOBULINEMIA; MORPHOMETRICS; MYELOMA; OSTEOLYSIS; OSTEOSCLEROSIS; PRIORITY JOURNAL; PROSTATE CANCER; BONE TUMOR; BREAST TUMOR; FEMALE; MALE; PATHOLOGY; PROSTATE TUMOR; RADIOGRAPHY; SECONDARY;

BONE AND BONES; BONE NEOPLASMS; BONE RESORPTION; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; OSTEOLYSIS; OSTEOSCLEROSIS; PROSTATIC NEOPLASMS; X-RAY MICROTOMOGRAPHY;

EID: 77954594206     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21150     Document Type: Article

References (52)

1. Alvarez E, Westmore M, Galvin RJ, Clapp CL, Considine EL, Smith SJ, Keyes K, Iversen PW, Delafuente DM, Sulaimon S, Zambrano C, Ma L, Sato M, Martin TJ, Teicher BA, Galbreath EJ. 2003. Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption. Clin Cancer Res 9:5705-5713.
2. Armstrong DJ, McCausland EMA, Wright GD. 2007. Hypertrophic pulmonary osteoarthropathy (HPOA) (Pierre Marie-Bamberger syndrome): two cases presenting as acute inflammatory arthritis. Description and review of the literature. Rheumatol Int 27:399-402.
3. Barillé-Nion S, Bataille R. 2003. New insights in myeloma-induced osteolysis. Leuk Lymphoma 44:1463-1467.
4. Baselga J, Rothenberg ML, Tabernero J, Seoane J, Daly T, Cleverly A, Berry B, Rhoades SK, Ray CA, Fill J, Farrington DL, Wallace LA, Yingling JM, Lahn M, Arteaga C, Carducci M. 2008. TGF-beta signalling-related markers in cancer patients with bone metastasis. Biomarkers 13:217-236.
5. Bataille R. 1997. New insights in the clinical biology of multiple myeloma. Semin Hematol 34:23-28. (Pubitemid 27057441)
6. Bataille R, Chappard D, Alexandre C, Dessauw P, Sany J. 1986. Importance of quantitative histology of bone changes in monoclonal gammopathy. Br J Cancer 53:805-810. (Pubitemid 16082038)
7. Blouin S, Baslé MF, Chappard D. 2005. Rat models of bone metastases. Clin Exp Metastasis 22:605-614.
8. Body JJ. 2003. Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions. Breast 12 Suppl 2:S37-S44.
9. Cereceda LE, Flechon A, Droz JP. 2003. Management of vertebral metastases in prostate cancer: a retrospective analysis in 119 patients. Clin Prostate Cancer 2:34-40. (Pubitemid 37012419)
10. Chappard D. 2009. Technical aspects: How do we best prepare bone samples for proper histological analysis? In: Heymann D, editor. Bone cancer: progression and therapeutic approaches. London: Acad. Press. Elsevier Inc. p 203-210.
11. Chappard D, Baslé MF, Legrand E, Audran M. 2008. Trabecular bone microarchitecture: a review. Morphologie 92:162-170.
12. Chappard D, Blouin S, Libouban H, Baslé MF, Audran M. 2005. Microcomputed tomography for the study of hard tissues and bone biomaterials. Microsc Anal 19:17-19. (Pubitemid 40633198)
13. Chappard D, Josselin N, Rougé-Maillart C, Legrand E, Baslé MF, Audran M. 2007. Bone microarchitecture in males with corticosteroid-induced osteoporosis. Osteoporos Int 18:487-494.
14. Chappard D, Rossi JF, Bataille R, Alexandre C. 1991. Osteoclast cytomorphometry demonstrates an abnormal population in B cell malignancies but not in multiple myeloma. Calcif Tissue Int 48:13-17.
15. Clézardin P, Teti A. 2007. Bone metastasis: pathogenesis and therapeutic implications. Clin Exp Metastasis 24:599-608.
16. Coleman RE. 1997. Skeletal complications of malignancy. Cancer 80:1588-1594.
17. Davis GR, Wong FS. 1996. X-ray microtomography of bones and teeth. Physiol Meas 17:121-146.
18. Deftos LJ. 2000. Prostate carcinoma: production of bioactive factors. Cancer Cell 88:3002-3008.
19. Fidler IJ. 2003. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3:453-458.
20. Fielder PJ, Rosenfeld RG, Graves HC, Grandbois K, Maack CA, Sawamura S, Ogawa Y, Sommer A, Cohen P. 1994. Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3. Growth Regul 4:164-172.
21. Garnero P, Buchs N, Zekri J, Rizzoli R, Coleman RE, Delmas PD. 2000. Markers of bone turnover for the management of patients with bone metastases from prostate cancer. Br J Cancer 82:858-864. (Pubitemid 30085239)
22. Gold LI. 1999. The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 10:303-360. (Pubitemid 30058460)
23. Guise TA, Chirgwin JM. 2003. Transforming growth factor-beta in osteolytic breast cancer bone metastases. Clin Orthop Relat Res 415S:32-38.
24. Guise TA, Mundy GR. 1998. Cancer and bone. Endocr Rev 19:18-54.
25. Hausmann M, Bataille F, Spoettl T, Schreiter K, Falk W, Schoelmerich J, Herfarth H, Rogler G. 2005. Physiological role of macrophage inflammatory protein-3 alpha induction during maturation of intestinal macrophages. J Immunol 175:1389-1398.
26. Hsu LM, Field R. 2003. Interrater agreement measures: comments on Kappan, Cohen's Kappa, Scott's π, and Aickin's α. Understanding Stat 2:205-219.
27. Josselin N, Dib M, Ifrah N, Legrand E, Baslé MF, Audran M, Chappard D. 2009. Quantification of dendritic cells and osteoclasts in the bone marrow of patients with monoclonal gammopathy. Pathol Oncol Res 15:65-72.
28. Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS. 2001. Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev 20:333-349.
29. Kostenuik PJ, Sanchez-Sweatman O, Orr FW, Singh G. 1996. Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin. Clin Exp Metastasis 14:19-26.
30. Kozak KR, Milne GL, Morrow JD, Cuiffo BP. 2006. Hypertrophic osteoarthropathy pathogenesis: a case highlighting the potential role for cyclo-oxygenase-2-derived prostaglandin E2. Nature Clin Pract Rheumatol 2:452-456.
31. Landis JR, Koch GG. 1977. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33:363-374.
32. Libouban H, Moreau MF, Lesourd M, Baslé MF, Chappard D. 2001. Osteolytic bone lesions in the 5T2 multiple myeloma model: radiographic, scanning electron microscopic and microtomographic studies. J Histotechnol 24:81-86. (Pubitemid 32565536)
33. Marcelli C, Chappard D, Rossi JF, Jaubert J, Alexandre C, Dessauw P, Baldet P, Bataille R. 1988. Histologic evidence of an abnormal bone remodeling in B-cell malignancies other than multiple myeloma. Cancer 62:1163-1170.
34. Morrissey C, Kostenuik PL, Brown LG, Vessella RL, Corey E. 2007. Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases. BMC Cancer 7:148.
35. Muller R, Hahn M, Vogel M, Delling G, Ruegsegger P. 1996. Morphometric analysis of noninvasively assessed bone biopsies: comparison of high-resolution computed tomography and histologic sections. Bone 18:215-220. (Pubitemid 26118116)
36. Muller R, Van Campenhout H, Van Damme B, Van Der Perre G, Dequeker J, Hildebrand T, Ruegsegger P. 1998. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone 23:59-66.
37. Mundy GR. 2002. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584-593.
38. Oshima T, Abe M, Asano J, Hara T, Kitazoe K, Sekimoto E, Tanaka Y, Shibata H, Hashimoto T, Ozaki S, Kido S, Inoue D, Matsumoto T. 2005. Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood 106:3160-3165.
39. Parfitt AM, Drezner MK, Glorieux FG, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
40. Polascik TJ, Oesterling JE, Partin AW. 1999. Prostate specific antigen: a decade of discovery - what we have learned and where we are going. J Urol 162:293-306.
41. Pugsley MK, Tabrizchi R. 2000. The vascular system. An overview of structure and function. J Pharmacol Toxicol Methods 44:333-340.
42. Roodman GD. 2004. Mechanisms of bone metastasis. N Engl J Med 350:1655-1664.
43. Ruegsegger P. 1994. The use of peripheral QCT in the evaluation of bone remodelling. Endocrinol 4:167-176. (Pubitemid 24174615)
44. Sahai E. 2007. Illuminating the metastatic process. Nat Rev Cancer 7:737-749.
45. Sasov A, Van Dyck D. 1998. Desktop X-ray microscopy and microtomography. J Microsc 191:151-158.
46. Schmidt A, Blanchet O, Dib M, Baslé MF, Ifrah N, Chappard D. 2007. Bone changes in myelofibrosis with myeloid metaplasia: a histomorphometric and microcomputed tomographic study. Eur J Haematol 78:500-509.
47. Sugihara A, Maeda O, Tsuji M, Tsujimura T, Nakata Y, Akedo H, Kotake T, Terada N. 1998. Expression of cytokines enhancing the osteoclast activity, and parathyroid hormone-related protein in prostatic cancers before and after endocrine therapy: an immunohistochemical study. Oncol Rep 5:1389-1394.
48. Thomas RJ, Guise TA, Yin JJ, Elliott J, Horwood NJ, Martin TJ, Gillespie MT. 1999. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140:4451-4458.
49. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr. 2003. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349:2483-2494.
50. Vela I, Gregory L, Gardiner EM, Clements JA, Nicol DL. 2007. Bone and prostate cancer cell interactions in metastatic prostate cancer. BJU Int 99:735-742.
51. Vessella RL, Corey E. 2006. Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis. Clin Cancer Res 12:6285s-6290s.
52. Wlodarski KH, Reddi HA. 1987. Tumor cells stimulate in vivo periosteal bone formation. Bone Miner 2:185-192.